Przejdź do trybu offline z Player FM !
Precision Medicine in Oncology: Ep.5 Precision medicine for metastatic colorectal cancer
Manage episode 303286166 series 2812899
In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss:
· The current standards for molecular testing in metastatic colorectal cancer
· The potential benefit of a Canadian guideline for molecular testing in metastatic colorectal cancer
Our guest:
Dr. Sharlene Gill is Professor of Medicine at the University of British Columbia and Medical Oncologist at BC Cancer in Vancouver. Dr. Gill earned her MD from the University of British Columbia and completed a fellowship in gastrointestinal oncology at the Mayo Clinic (Rochester, MN). She also received a Master of Public Health degree from the Harvard School of Public Health and completed her MBA at the Kenan-Flagler School of Business at the University of North Carolina. Dr. Gill currently specializes in the treatment of gastrointestinal malignancies and serves as the Chair of the Canadian Clinical Trials Group GI Disease Site Committee. In addition, she is President-Elect of the Canadian Association of Medical Oncologists and is Editor-in-Chief for the peer-reviewed journal Current Oncology.
This podcast episode was sponsored by Merck Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
68 odcinków
Manage episode 303286166 series 2812899
In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss:
· The current standards for molecular testing in metastatic colorectal cancer
· The potential benefit of a Canadian guideline for molecular testing in metastatic colorectal cancer
Our guest:
Dr. Sharlene Gill is Professor of Medicine at the University of British Columbia and Medical Oncologist at BC Cancer in Vancouver. Dr. Gill earned her MD from the University of British Columbia and completed a fellowship in gastrointestinal oncology at the Mayo Clinic (Rochester, MN). She also received a Master of Public Health degree from the Harvard School of Public Health and completed her MBA at the Kenan-Flagler School of Business at the University of North Carolina. Dr. Gill currently specializes in the treatment of gastrointestinal malignancies and serves as the Chair of the Canadian Clinical Trials Group GI Disease Site Committee. In addition, she is President-Elect of the Canadian Association of Medical Oncologists and is Editor-in-Chief for the peer-reviewed journal Current Oncology.
This podcast episode was sponsored by Merck Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
68 odcinków
All episodes
×![Artwork](/static/images/128pixel.png)
1 Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape 17:37
![Artwork](/static/images/128pixel.png)
1 Highlights from EHA 2024 - Updates on the Treatment of CLL 42:13
![Artwork](/static/images/128pixel.png)
1 LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL 16:33
![Artwork](/static/images/128pixel.png)
1 Cutting Edge Advances in the Treatment of Lung Cancer 15:13
![Artwork](/static/images/128pixel.png)
1 Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers 41:28
![Artwork](/static/images/128pixel.png)
1 Immunotherapy for Kidney Transplant Patients with Skin Cancer 21:32
![Artwork](/static/images/128pixel.png)
1 Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective 24:11
![Artwork](/static/images/128pixel.png)
1 LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM 16:58
![Artwork](/static/images/128pixel.png)
1 Live from ASH 2023: Dr Brown Discusses Updated Results of the ALPINE Trial in CLL 13:48
![Artwork](/static/images/128pixel.png)
1 First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on 1L LA/mUC 32:28
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion 26:41
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion 8:07
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment 14:52
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs 10:38
Zapraszamy w Player FM
Odtwarzacz FM skanuje sieć w poszukiwaniu wysokiej jakości podcastów, abyś mógł się nią cieszyć już teraz. To najlepsza aplikacja do podcastów, działająca na Androidzie, iPhonie i Internecie. Zarejestruj się, aby zsynchronizować subskrypcje na różnych urządzeniach.